FindTrial
Sign In

Application of Healsoon haemostatic powder in gastrointestinal bleeding lesions under gastrointestinal endoscopy

Application of Healsoon haemostatic powder in gastrointestinal bleeding lesions under gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052457
Enrollment
Unknown
Registered
2021-10-26
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding

Interventions

group 2:Healsoon haemostatic powder for haemostatic treatment
Group 1:Traditional haemostatic treatment

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Aged >14 years. 2.Endoscopic finding of a bleeding lesion with oozing blood as the main manifestation.

Exclusion criteria

Exclusion criteria: 1. Refuse endoscopic hemostasis treatment; 2. The current diagnosis of disseminated intravascular coagulation; 3. Patients with congenital coagulation factor deficiency, such as hemophilia; 4. Allergy to starch; 5. Not signing informed consent; 6. Currently included in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Endoscopic haemostasis success rate;—

Countries

China

Contacts

Public ContactXiao Xue

West China Hospital, Sichuan University

xiaoxue@wchscu.cn+86 15982175701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026